• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

World J Virol . Reinfection risk of novel coronavirus (COVID-19): A systematic ‎review of current evidence

tetano

Editor, Senior Moderator
World J Virol


. 2020 Dec 15;9(5):79-90.
doi: 10.5501/wjv.v9.i5.79.
Reinfection risk of novel coronavirus (COVID-19): A systematic ‎review of current evidence


SeyedAhmad SeyedAlinaghi[SUP] 1 [/SUP], Shahram Oliaei[SUP] 2 [/SUP], Shaghayegh Kianzad[SUP] 3 [/SUP], Amir Masoud Afsahi[SUP] 4 [/SUP], Mehrzad MohsseniPour[SUP] 1 [/SUP], Alireza Barzegary[SUP] 5 [/SUP], Pegah Mirzapour[SUP] 1 [/SUP], Farzane Behnezhad[SUP] 6 [/SUP], Tayebeh Noori[SUP] 7 [/SUP], Esmaeil Mehraeen[SUP] 8 [/SUP], Omid Dadras[SUP] 9 [/SUP], Fabricio Voltarelli[SUP] 10 [/SUP], Jean-Marc Sabatier[SUP] 11 [/SUP]



Affiliations
Free PMC article

Abstract

Background: There is recently a concern regarding the reinfection and reactivation of previously reCoVered coronavirus disease 2019 (CoVID-19) patients.
Aim: To summarize the recent findings and reports of CoVID-19 reinfection in patients previously reCoVered from the disease.
Methods: This study was a systematic review of current evidence conducted in August 2020. The authors studied the probable reinfection risk of novel coronavirus (CoVID-19). We performed a systematic search using the keywords in online databases. The investigation adheres to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist to ensure the reliability and validity of this study and results.
Results: We reviewed 31 studies. Eight studies described reCoVered patients with reinfection. Only one study reported reinfected patients who died. In 26 studies, there was no information about the status of the patients. Several studies indicated that reinfection is not probable and that post-infection immunity is at least temporary and short.
Conclusion: Based on our review, we concluded that a positive polymerase chain reaction retest could be due to several reasons and should not always be considered as reinfection or reactivation of the disease. Most relevant studies in positive retest patients have shown relative and probably temporary immunity after the reCoVery of the disease.

Keywords: CoVID-19; Coronavirus; Postinfection; Reactivation; Reinfection; SARS-CoV-2.
 
Back
Top Bottom